Brief: Orchard Therapeutics Reports Q3 Loss Per Share $0.20
03/11/2020 12:33
Nov 3 (Reuters) - Orchard Therapeutics PLC ORTX.O :
* ORCHARD THERAPEUTICS REVIEWS RECENT PORTFOLIO PROGRESS AND
REPORTS THIRD QUARTER 2020 FINANCIAL RESULTS
* QTRLY NET PRODUCT SALES $2 MILLION VERSUS $1.92 MILLION
* QTRLY LOSS PER SHARE $0.20
* Q3 EARNINGS PER SHARE VIEW $-0.46, REVENUE VIEW $109330.00
--
REFINITIV IBES DATA
Source text for Eikon: ID:nGNX9KsDjn
Further company coverage: ORTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Orchard Therapeutics
See all newsBrief: Orchard Therapeutics Says Court Of Justice Of England & Wales Sanctioned Scheme Of Arrangement Providing For Acquisition Of Co By Kyowa Kirin Co's Unit
Brief: Orchard Therapeutics Receives U.S. FDA Fast Track Designation For OTL-203 In MPS-IH
Brief: Orchard Therapeutics Says U.S. FDA Advised Co It Does Not Intend To Schedule Advisory Committee Meeting
Orchard Therapeutics rises on buyout deal by Japanese drugmaker
Kyowa Kirin to acquire Orchard Therapeutics for $478 mln